Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia A
Clinical trial NCT02994407 · COMPLETED
Trial details
- NCT number
- NCT02994407
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-30
- Primary completion
- 2018-10-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.